Liquid Biopsy Market is expected to surpass US$ 5 Billion mark by 2025 | MDxHealth, Clearbridge BioMedics, Exosome Diagnostics

Liquid Biopsy Market is expected to surpass US$ 5 Billion mark by 2025 | MDxHealth, Clearbridge BioMedics, Exosome Diagnostics

“Liquid Biopsy Market”
A new independent 305 page research with title ‘Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding and 20 Company Profile – Forecast to 2025’ guarantees you will remain better informed than your competition.

The study covers geographic analysis that includes regions like North America, Europe, Asia-Pacific, South America, Middle East and Africa and important players/vendors such as Personal Genome Diagnostics, Guardant Health, Inc., Pathway Genomics, RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.) Etc. With n-number of tables and figures examining the Liquid Biopsy Market, the research gives you a visual, one-stop breakdown of the leading products, submarkets and market leader’s market revenue forecasts as well as analysis to 2025.

Get customization & check discount for report @ https://www.htfmarketreport.com/request-discount/987300-global-liquid-biopsy-market-6

Summary
The global liquid biopsy market is expected to surpass US$ 5 Billion mark by 2025.
Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization of new lesions, drug & therapeutic target identifications for cancer treatment are some advantages of liquid biopsies, which improve the safety and efficiency of cancer therapy for patients.
    
The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, growing public and private funding to support research activities in the field of liquid biopsy and favorable government initiatives, are some of the factors expected to propel the growth of liquid biopsy market in the coming years. Some of the key factors inhibiting the growth of liquid biopsy market includes, clinical utility challenges, lack of sensitivity and specificity of liquid biopsy tests and unclear reimbursement & regulation scenario. 
 
Request a sample report @ https://www.htfmarketreport.com/sample-report/987300-global-liquid-biopsy-market-6

Global Liquid Biopsy Market & Forecast – by Circulating Biomarker (2015 – 2025)
1. Circulating Tumor Cells (CTCs)
2. Circulating Tumor DNA (ctDNA)
3. Cell-Free DNA (cfDNA)
4. Extracellular Vesicles (EVs)
5. Other Circulating Biomarkers

Global Liquid Biopsy Market & Forecast – by Product (2015 – 2025)
1. Kits and Consumables
2. Instruments
3. Services

Global Liquid Biopsy Market & Forecast – by Application (2015 – 2025)
1. Oncology Application
• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Gastrointestinal Cancer
• Leukaemia
• Others
2. Non-Cancer Application

Global Liquid Biopsy Oncology Market & Forecast – by Clinical Application (2015 – 2025)
1. Therapy Selection
2. Treatment Monitoring
3. Early Cancer Screening
4. Recurrence Monitoring

Global Liquid Biopsy Market & Forecast – by End User (2015 – 2025)
1. Reference Laboratories
2. Hospitals and Physician Laboratories
3. Academic and Research Centers
4. Other End Users

Global Liquid Biopsy Market & Forecast – by Sample Type (2015 – 2025)
1. Blood Sample
2. Urine Sample
3. Other Fluids Sample

Liquid Biopsy Market & Forecast –  Regional Analysis (2015 – 2025)
North America (U.S., Canada)
Europe (UK, Germany)
Asia Pacific (China, India, Japan)
Latin America (Brazil, Mexico)
Rest of the World

Place a Purchase Order for this Market Study (Single User License) at: https://www.htfmarketreport.com/buy-now?format=1&report=987300

Liquid Biopsy Market –  Company Profiles
Personal Genome Diagnostics, Guardant Health, Inc., Pathway Genomics, RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.), Trovagene, Inc, Cynvenio Biosystems, Inc., Biocept, Inc., ANGLE plc, MDxHealth, Clearbridge BioMedics Pte Ltd, Exosome Diagnostics, Inc, Foundation Medicine, Inc, Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG), Genomic Health, Myriad Genetics, Inc, Thermo Fisher Scientific, Inc, QIAGEN NV, Bio-Rad Laboratories, Inc, Menarini-Silicon Biosystems, GRAIL

Data Sources: HTF MI RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by HTF MI Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies: Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

1. Executive Summary
2. Global Liquid Biopsy Market & Forecast (2015 – 2025)
3. Global Liquid Biopsy Market Share & Forecast (2015 – 2025)
3.1 Global Liquid Biopsy Market Share & Forecast – by Circulating Biomarker
3.2 Global Liquid Biopsy Market Share & Forecast – by Product
3.3 Global Liquid Biopsy Market Share & Forecast – by Application
3.4 Global Liquid Biopsy Oncology Market Share & Forecast – by Clinical Application
3.5 Global Liquid Biopsy Oncology Market Share & Forecast – By Cancer Types
3.6 Global Liquid Biopsy Market Share & Forecast – by End User
3.7 Global Liquid Biopsy Market Share & Forecast – by Sample Type
3.8 Liquid Biopsy Market Share & Forecast –  Regional Analysis
3.9 Liquid Biopsy Market Share & Forecast – Country Wise Analysis

4. Global Liquid Biopsy Market & Forecast – by Circulating Biomarker (2015 – 2025)
5. Global Liquid Biopsy Market & Forecast – by Product (2015 – 2025)
6. Global Liquid Biopsy Market & Forecast – by Application (2015 – 2025)
7. Global Liquid Biopsy Oncology Market & Forecast – by Clinical Application (2015 – 2025)
8. Global Liquid Biopsy Market & Forecast – by End User (2015 – 2025)
9. Global Liquid Biopsy Market & Forecast – by Sample Type (2015 – 2025)
….Continued

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/987300-global-liquid-biopsy-market-6

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Author:
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.

Media Contact
Company Name: HTF Market Intelligence Consulting Private Limited
Contact Person: Craig Francis
Email: Send Email
Phone: 2063171218
Address:Unit No. 429, Parsonage Road
City: Edison
State: New Jersey
Country: United States
Website: https://www.htfmarketreport.com/reports/987300-global-liquid-biopsy-market-6